Cassava Sciences Inc (SAVA)
26.21
+0.40
(+1.57%)
USD |
NASDAQ |
Nov 01, 16:00
26.11
-0.10
(-0.38%)
After-Hours: 20:00
Cassava Sciences Price to Book Value: 6.654 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 6.654 |
| October 31, 2024 | 6.551 |
| October 30, 2024 | 6.601 |
| October 29, 2024 | 6.733 |
| October 28, 2024 | 6.786 |
| October 25, 2024 | 6.740 |
| October 24, 2024 | 6.928 |
| October 23, 2024 | 7.106 |
| October 22, 2024 | 7.218 |
| October 21, 2024 | 7.332 |
| October 18, 2024 | 7.362 |
| October 17, 2024 | 7.508 |
| October 16, 2024 | 7.522 |
| October 15, 2024 | 7.175 |
| October 14, 2024 | 6.982 |
| October 11, 2024 | 6.55 |
| October 10, 2024 | 6.311 |
| October 09, 2024 | 6.347 |
| October 08, 2024 | 6.614 |
| October 07, 2024 | 6.451 |
| October 04, 2024 | 6.875 |
| October 03, 2024 | 6.844 |
| October 02, 2024 | 6.840 |
| October 01, 2024 | 6.961 |
| September 30, 2024 | 7.472 |
| Date | Value |
|---|---|
| September 27, 2024 | 7.232 |
| September 26, 2024 | 8.091 |
| September 25, 2024 | 7.736 |
| September 24, 2024 | 7.510 |
| September 23, 2024 | 6.856 |
| September 20, 2024 | 7.560 |
| September 19, 2024 | 7.708 |
| September 18, 2024 | 7.698 |
| September 17, 2024 | 7.946 |
| September 16, 2024 | 7.195 |
| September 13, 2024 | 7.139 |
| September 12, 2024 | 7.172 |
| September 11, 2024 | 6.938 |
| September 10, 2024 | 6.855 |
| September 09, 2024 | 6.837 |
| September 06, 2024 | 6.832 |
| September 05, 2024 | 7.477 |
| September 04, 2024 | 7.535 |
| September 03, 2024 | 7.104 |
| August 30, 2024 | 7.289 |
| August 29, 2024 | 7.238 |
| August 28, 2024 | 6.781 |
| August 27, 2024 | 7.314 |
| August 26, 2024 | 7.555 |
| August 23, 2024 | 7.858 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.223
Minimum
Nov 18 2019
33.61
Maximum
Feb 03 2021
7.146
Average
6.381
Median
Price to Book Value Benchmarks
| Bristol-Myers Squibb Co | 6.427 |
| Eli Lilly and Co | 54.59 |
| Seelos Therapeutics Inc | -- |
| Biomarin Pharmaceutical Inc | 2.345 |
| EyePoint Pharmaceuticals Inc | 2.827 |
Price to Book Value Related Metrics
| PS Ratio | 27.81 |
| Price | 26.21 |
| Earnings Yield | -5.38% |
| Market Cap | 1.257B |
| Operating PE Ratio | 36.45 |
| Normalized PE Ratio | 5.506 |